Zhengye Biotechnology Holding Limited Shareholders' Equity
Zhengye Biotechnology Holding Limited (ZYBT) had Shareholders' Equity of CNY 249.85 million as of 2025-12-31, per its 20-F filed 2026-04-28.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-04-28
- 2025-12-31: Stockholders' Equity Attributable to Parent 249.85M CNY.
- 2025-06-30: Stockholders' Equity Attributable to Parent 298.92M CNY.
- 2024-12-31: Stockholders' Equity Attributable to Parent 283.96M CNY.
- 2023-12-31: Stockholders' Equity Attributable to Parent 272.85M CNY.
CNY
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2025-12-31 | 249.85M CNY 20-F · filed 2026-04-28 |
| 2025-06-30 | 298.92M CNY 6-K · filed 2025-12-12 |
| 2024-12-31 | 283.96M CNY 20-F · filed 2026-04-28 |
| 2023-12-31 | 272.85M CNY 20-F · filed 2025-07-03 |
USD
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2025-12-31 | $35.72M 20-F · filed 2026-04-28 |
| 2025-06-30 | $41.73M 6-K · filed 2025-12-12 |
| 2024-12-31 | $38.90M 20-F · filed 2025-07-03 |